Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Intensive Care Medicine
Published in: Intensive Care Medicine 10/2015

01-10-2015 | Systematic Review

Extracorporeal carbon dioxide removal in patients with chronic obstructive pulmonary disease: a systematic review

Authors: Michael C. Sklar, Francois Beloncle, Christina M. Katsios, Laurent Brochard, Jan O. Friedrich

Published in: Intensive Care Medicine | Issue 10/2015

Login to get access

Abstract

Introduction

Extracorporeal carbon dioxide removal (ECCO2R) has been proposed for hypercapnic respiratory failure in chronic obstructive pulmonary disease (COPD) exacerbations, to avoid intubation or reduce length of invasive ventilation. Balance of risks, efficacy, and benefits of ECCO2R in patients with COPD is unclear.

Methods

We systematically searched MEDLINE and EMBASE to identify all publications reporting use of ECCO2R in COPD. We looked at physiological and clinical efficacy. A favorable outcome was defined as prevention of intubation or successful extubation. Major and minor complications were compiled.

Results

We identified 3123 citations. Ten studies (87 patients), primarily case series, met inclusion criteria. ECCO2R prevented intubation in 65/70 (93 %) patients and assisted in the successful extubation of 9/17 (53 %) mechanically ventilated subjects. One case–control study matching to noninvasively ventilated controls reported lower intubation rates and hospital mortality with ECCO2R that trended toward significance. Physiological data comparing pre- to post-ECCO2R changes suggest improvements for pH (0.07–0.15 higher), PaCO2 (25 mmHg lower), and respiratory rate (7 breaths/min lower), but not PaO2/FiO2. Studies reported 11 major (eight bleeds requiring blood transfusion of 2 units, and three line-related complications, including one death related to retroperitoneal bleeding) and 30 minor complications (13 bleeds, five related to anticoagulation, and nine clotting-related device malfunctions resulting in two emergent intubations).

Conclusion

The technique is still experimental and no randomized trial is available. Recognizing selection bias associated with case series, there still appears to be potential for benefit of ECCO2R in patients with COPD exacerbations. However, it is associated with frequent and potentially severe complications. Higher-quality studies are required to better elucidate this risk–benefit balance.
Appendix
Available only for authorised users
Literature
1.
Decramer M, Janssens W, Miravitlles M (2012) Chronic obstructive pulmonary disease. Lancet 379:1341–1351CrossRefPubMed
2.
Soler-Cataluña JJ, Martínez-García MÁ, Sánchez PR et al (2005) Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 60:925–931PubMedCentralCrossRefPubMed
3.
Connors AF, Dawson NV, Thomas C et al (1996) Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 154:959–967CrossRefPubMed
4.
Hoogendoorn M, Hoogenveen RT, Rutten-van Mölken MP et al (2011) Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach. Eur Respir J 37:508–515CrossRefPubMed
5.
Chandra D, Stamm JA, Taylor B et al (2012) Outcomes of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease in the United States, 1998–2008. Am J Respir Crit Care Med 185:152–159PubMedCentralCrossRefPubMed
6.
Brochard L, Mancebo J, Wysocki M et al (1995) Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 333:817–822CrossRefPubMed
7.
Quinnell TG, Pilsworth S, Shneerson JM, Smith IE (2006) Prolonged invasive ventilation following acute ventilatory failure in COPD: weaning results, survival, and the role of noninvasive ventilation. Chest 129:133–139CrossRefPubMed
8.
Hoo GW, Hakimian N, Santiago SM (2000) Hypercapnic respiratory failure in COPD patients: response to therapy. Chest 117:169–177CrossRefPubMed
9.
Chu CM, Chan VL, Lin AWN et al (2004) Readmission rates and life threatening events in COPD survivors treated with non-invasive ventilation for acute hypercapnic respiratory failure. Thorax 59:1020–1025PubMedCentralCrossRefPubMed
10.
Menzies R, Gibbons W, Goldberg P (1989) Determinants of weaning and survival among patients with COPD who require mechanical ventilation for acute respiratory failure. Chest 95:398–405CrossRefPubMed
11.
Schönhofer B, Euteneuer S, Nava S et al (2002) Survival of mechanically ventilated patients admitted to a specialised weaning centre. Intensive Care Med 28:908–916CrossRefPubMed
12.
Gattinoni L, Agostoni A, Pesenti A (1980) Treatment of acute respiratory failure with low-frequency positive-pressure ventilation and extracorporeal removal of CO2. Lancet 2:292–294CrossRefPubMed
13.
Gattinoni L, Pesenti A, Mascheroni D et al (1986) Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure. JAMA 256:881–886CrossRefPubMed
14.
Terragni PP, Del Sorbo L, Mascia L et al (2009) Tidal volume lower than 6 mL/kg enhances lung protection: role of extracorporeal carbon dioxide removal. Anesthesiology 111:826–835CrossRefPubMed
15.
Bein T, Weber-Carstens S, Goldmann A et al (2013) Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO2 removal versus conventional protective ventilation (6 ml/kg) in severe ARDS: the prospective randomized Xtravent-study. Intensive Care Med 39:847–856PubMedCentralCrossRefPubMed
16.
Bein T, Weber F, Philipp A et al (2006) A new pumpless extracorporeal interventional lung assist in critical hypoxemia/hypercapnia. Crit Care Med 34:1372–1377CrossRefPubMed
17.
Nierhaus A, Frings D, Braune S et al (2011) Interventional lung assist enables lung protective mechanical ventilation in acute respiratory distress syndrome. Minerva Anestesiol 77:797–801PubMed
18.
Fitzgerald M, Millar J, Blackwood B et al (2014) Extracorporeal carbon dioxide removal for patients with acute respiratory failure secondary to the acute respiratory distress syndrome: a systematic review. Crit Care 18:222PubMedCentralCrossRefPubMed
19.
20.
Higgins JPT, Green S (2011) Cochrane handbook for systematic reviews of interventions. Wiley, USA
21.
22.
23.
24.
25.
26.
27.
Kluge S (2013) Extracorporeal lung assist to avoid intubation in patients failing noninvasive ventilation for acute hypercapnic respiratory Failure (ECLAIR). http://​Clinicaltrials.​gov. NCT01784367
28.
29.
Bonin F, Sommerwerck U, Lund LW, Teschler H (2013) Avoidance of intubation during acute exacerbation of chronic obstructive pulmonary disease for a lung transplant candidate using extracorporeal carbon dioxide removal with the Hemolung. J Thorac Cardiovasc Surg 145:e43–e44CrossRefPubMed
30.
Crotti S, Lissoni A, Tubiolo D et al (2012) Artificial lung as an alternative to mechanical ventilation in COPD exacerbation. Eur Respir J 39:212–215CrossRefPubMed
31.
Cardenas VJ Jr, Lynch JE, Ates R et al (2009) Venovenous carbon dioxide removal in chronic obstructive pulmonary disease experience in one patient. ASAIO J 55:420–422CrossRefPubMed
32.
Abrams DC, Brenner K, Burkart KM et al (2013) Pilot study of extracorporeal carbon dioxide removal to facilitate extubation and ambulation in exacerbations of chronic obstructive pulmonary disease. Ann Am Thorac Soc 10:307–314CrossRefPubMed
33.
Burki N, Mani R, Herth F, Schmidt W, Teschler H, Bonin F (2011) A novel extracorporeal CO2 removal system: application of the hemolung in patients with hypercapnic respiratory failure. Am J Respir Crit Care Med 183:A1697
34.
Mani RK, Schmidt W, Lund LW, Herth FJF (2013) Respiratory dialysis for avoidance of intubation in acute exacerbation of COPD. ASAIO J 59:675–678CrossRefPubMed
35.
Spinelli E, Crotti S, Zacchetti L et al (2013) Effect of extracorporeal CO2 removal on respiratory rate in spontaneously breathing patients with chronic obstructive pulmonary disease exacerbation. Crit Care 17:S48CrossRef
36.
Burki NK, Mani RK, Herth FJF et al (2013) A novel extracorporeal CO(2) removal system: results of a pilot study of hypercapnic respiratory failure in patients with COPD. Chest 143:678–686PubMedCentralPubMed
37.
Del Sorbo L, Pisani L, Filippini C et al (2014) Extracorporeal CO2 Removal in hypercapnic patients at risk of noninvasive ventilation failure: a matched cohort study with historical control. Crit Care Med 43:120–127CrossRef
38.
Kluge S, Braune SA, Engel M et al (2012) Avoiding invasive mechanical ventilation by extracorporeal carbon dioxide removal in patients failing noninvasive ventilation. Intensive Care Med 38:1632–1639CrossRefPubMed
39.
Beloncle F, Brochard L (2015) Extracorporeal CO2 removal for chronic obstructive pulmonary disease: too risky or ready for a trial? Crit Care Med 43:245–246CrossRefPubMed
40.
Roux D, Reignier J, Thiery G et al (2014) Acquiring procedural skills in ICUs: a prospective multicenter study. Crit Care Med 42:886–895CrossRefPubMed
41.
Ruesch S, Walder B, Tramèr MR (2002) Complications of central venous catheters: internal jugular versus subclavian access–a systematic review. Crit Care Med 30:454–460CrossRefPubMed
42.
Bambauer R, Latza R (2004) Complications in large-bore catheters for extracorporeal detoxification methods. Artif Organs 28:629–633CrossRefPubMed
43.
Ciani O, Buyse M, Garside R et al (2013) Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study. BMJ 346:f457PubMedCentralCrossRefPubMed
Metadata
Title
Extracorporeal carbon dioxide removal in patients with chronic obstructive pulmonary disease: a systematic review
Authors
Michael C. Sklar
Francois Beloncle
Christina M. Katsios
Laurent Brochard
Jan O. Friedrich
Publication date
01-10-2015
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 10/2015
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-015-3921-z

Other articles of this Issue 10/2015

Intensive Care Medicine 10/2015 Go to the issue

Letter

Early lactate clearance-guided therapy in patients with sepsis: a meta-analysis with trial sequential analysis of randomized controlled trials

Review

Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting

Editorial

From weaning theory to practice: implementation of a quality improvement program in ICU

What's New in Intensive Care

Ten strategies to increase survival of cardiac arrest patients

Imaging in Intensive Care Medicine

Acute ruptured mycotic aneurysm mimicking myocardial tumor with ST elevation myocardial infarction

Letter

Prolonged extracorporeal membrane oxygenation and lung transplantation for isolated pulmonary anti-GBM (Goodpasture) disease